{
  "resourceType": "ClinicalUseDefinition",
  "id": "example-interaction",
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "brr"
    }
  ],
  "type": "interaction",
  "subject": [
    {
      "reference": {
        "reference": "MedicinalProductDefinition/example"
      }
    }
  ],
  "interaction": {
    "interactant": [
      {
        "itemCodeableConcept": {
          "coding": [
            {
              "system": "http://ema.europa.eu/example/interactant",
              "code": "alphaconazole"
            }
          ]
        }
      },
      {
        "itemCodeableConcept": {
          "coding": [
            {
              "system": "http://ema.europa.eu/example/interactant",
              "code": "betaconazole"
            }
          ]
        }
      }
    ],
    "type": {
      "coding": [
        {
          "system": "http://ema.europa.eu/example/interactionsType",
          "code": "Inhibitor"
        }
      ]
    },
    "effect": {
      "concept": {
        "text": "Increased plasma concentration"
      }
    },
    "management": [
      {
        "text": "Careful monitoring of dose"
      }
    ]
  },
  "meta": {
    "tag": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason",
        "code": "HTEST",
        "display": "test health data"
      }
    ]
  }
}